UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000054940 |
|---|---|
| Receipt number | R000062765 |
| Scientific Title | Retrospective Analysis of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Differences in Outcome According to the Presence or Absence of Lung Metastases |
| Date of disclosure of the study information | 2024/07/11 |
| Last modified on | 2024/07/11 17:35:47 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Retrospective Analysis of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Differences in Outcome According to the Presence or Absence of Lung Metastases
Acronym
Retrospective Analysis of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Differences in Outcome According to the Presence or Absence of Lung Metastases
Scientific Title
Retrospective Analysis of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Differences in Outcome According to the Presence or Absence of Lung Metastases
Scientific Title:Acronym
Retrospective Analysis of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Differences in Outcome According to the Presence or Absence of Lung Metastases
Region
| Japan |
Condition
Condition
Adenoid Cystic Carcinoma of the head and neck
Classification by specialty
| Radiology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
Evaluate differences in treatment outcomes
Basic objectives2
Others
Basic objectives -Others
Risk factor
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Local control rate, progression-free survival, and overall survival.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Adenoid cystic carcinoma cases treated with carbon ion raditaion therapy from April 1997 to March 2024 in our hospital.
Key exclusion criteria
Patients who have refused to use the data.
Target sample size
476
Research contact person
Name of lead principal investigator
| 1st name | Hiroaki |
| Middle name | |
| Last name | Ikawa |
Organization
National Institutes for Quantum Science and Technology (QST)
Division name
QST hospital
Zip code
283-8555
Address
4-9-1, Anagawa, Inage, Chiba city, Chiba, Japan
TEL
0432063306
ikawa.hiroaki@qst.go.jp
Public contact
Name of contact person
| 1st name | Hiroaki |
| Middle name | |
| Last name | Ikaw |
Organization
National Institutes for Quantum Science and Technology (QST)
Division name
QST Hospital
Zip code
263-8555
Address
4-9-1, Anagawa, Inage, Chiba city, Chiba, Japan
TEL
0432063306
Homepage URL
ikawa.hiroaki@qst.go.jp
Sponsor or person
Institute
National Institutes for Quantum Science and Technology (QST)
Institute
Department
Personal name
Funding Source
Organization
National Institutes for Quantum Science and Technology (QST)
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
National Institutes for Quantum Science and Technology (QST)
Address
4-9-1, Anagawa, Inage, Chiba city, Chiba, Japan
Tel
0432063306
ikawa.hiroaki@qst.go.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 07 | Month | 11 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Open public recruiting
Date of protocol fixation
| 2024 | Year | 07 | Month | 11 | Day |
Date of IRB
| 2024 | Year | 07 | Month | 11 | Day |
Anticipated trial start date
| 2024 | Year | 07 | Month | 11 | Day |
Last follow-up date
| 2029 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
N/A
Management information
Registered date
| 2024 | Year | 07 | Month | 11 | Day |
Last modified on
| 2024 | Year | 07 | Month | 11 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062765
